Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES

NCT07305350 is registered in ClinicalTrials.gov with University of Child Health Sciences and Children's Hospital, Lahore as lead sponsor.

NCT NCT07305350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07305350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES
Lead sponsor
University of Child Health Sciences and Children's Hospital, Lahore
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 10, 2025
Completion date
May 10, 2026
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic ischaemic encephalopathy (hie)